{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:02:38Z","timestamp":1778673758892,"version":"3.51.4"},"reference-count":32,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.3201\/eid1907.121830","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T18:25:19Z","timestamp":1370975119000},"page":"1074-1083","source":"Crossref","is-referenced-by-count":193,"title":["Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999\u201320111"],"prefix":"10.3201","volume":"19","author":[{"given":"Sandra S.","family":"Richter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristopher P.","family":"Heilmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassie L.","family":"Dohrn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fathollah","family":"Riahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Diekema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary V.","family":"Doern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid1907.121830-201306171129-R1","first-page":"93","article-title":"Pneumococcal conjugate vaccine for childhood immunization: WHO position paper.","volume":"82","author":"World Health Organization","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"key-10.3201\/eid1907.121830-201306171129-R2","unstructured":"Centers for Disease Control and Prevention. Active bacterial core surveillance report. Emerging infections program network,Streptococcus pneumoniae, 2010 [cited 2103 Feb 24]. http:\/\/www.cdc.gov\/abcs\/reports-findings\/survreports\/spneu00.html"},{"key":"key-10.3201\/eid1907.121830-201306171129-R3","unstructured":"Atkinson W, Wolfe S, Hamborsky J, editors. Epidemiology and prevention of vaccine-preventable diseases. 12th ed. Washington (DC): Public Health Foundation; 2012."},{"key":"key-10.3201\/eid1907.121830-201306171129-R4","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1128\/AAC.45.6.1721-1729.2001","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u201395.","volume":"45","author":"Doern","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1907.121830-201306171129-R5","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1056\/NEJM200012283432603","article-title":"Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.","volume":"343","author":"Whitney","year":"2000","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid1907.121830-201306171129-R6","first-page":"1","article-title":"Advisory Committee on immunization Practices. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"49","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid1907.121830-201306171129-R7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.","volume":"360","author":"Hsu","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid1907.121830-201306171129-R8","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.","volume":"354","author":"Kyaw","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid1907.121830-201306171129-R9","first-page":"343","article-title":"Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of the 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24\u201359 months who are not completely vaccinated.","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1907.121830-201306171129-R10","first-page":"258","article-title":"Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children. Advisory Committee on Immunization Practices (ACIP).","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1907.121830-201306171129-R11","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1128\/JCM.02199-06","article-title":"Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae.","volume":"45","author":"Park","year":"2007","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid1907.121830-201306171129-R12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1099\/mic.0.034116-0","article-title":"Identification of natural pneumococcal isolates expressing serotype 6D by genetic, biochemical and serological characterization.","volume":"156","author":"Bratcher","year":"2010","journal-title":"Microbiology"},{"key":"key-10.3201\/eid1907.121830-201306171129-R13","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1086\/650496","article-title":"Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era.","volume":"201","author":"Gertz","year":"2010","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1907.121830-201306171129-R14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/infdis\/jir755","article-title":"Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines.","volume":"205","author":"Hampton","year":"2012","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1907.121830-201306171129-R15","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1183\/09031936.00041210","article-title":"The paradox of pneumococcal serotypes: highly invasive does not mean highly lethal.","volume":"36","author":"Pletz","year":"2010","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid1907.121830-201306171129-R16","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1183\/09031936.00176309","article-title":"Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia.","volume":"36","author":"Luj\u00e1n","year":"2010","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid1907.121830-201306171129-R17","doi-asserted-by":"publisher","first-page":"e1000081","DOI":"10.1371\/journal.pmed.1000081","article-title":"Pneumococcal serotype and mortality following invasive pneumococcal disease: a population-based cohort study.","volume":"6","author":"Harboe","year":"2009","journal-title":"PLoS Med"},{"key":"key-10.3201\/eid1907.121830-201306171129-R18","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-first informational supplement, CLSI document M100\u2013S21. Wayne (PA): The Institute; 2011."},{"key":"key-10.3201\/eid1907.121830-201306171129-R19","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 8th ed., CLSI document M7\u2013A8. Wayne (PA): The Institute; 2009."},{"key":"key-10.3201\/eid1907.121830-201306171129-R20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1086\/338065","article-title":"The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994\u20132000.","volume":"34","author":"Richter","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1907.121830-201306171129-R21","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1086\/595857","article-title":"Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004\u201305.","volume":"48","author":"Richter","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1907.121830-201306171129-R22","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1128\/AAC.00582-12","article-title":"In vitro activity of ceftaroline against clinical isolates of Streptococcus pneumoniae recoverd in 43 U.S. medical centers during 2010\u20132011.","volume":"56","author":"Doern","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1907.121830-201306171129-R23","first-page":"394","article-title":"Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and older.","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid1907.121830-201306171129-R24","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1016\/j.vaccine.2012.05.076","article-title":"Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged \u226550 years.","volume":"30","author":"Weycker","year":"2012","journal-title":"Vaccine"},{"key":"key-10.3201\/eid1907.121830-201306171129-R25","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1086\/528996","article-title":"Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.","volume":"197","author":"Moore","year":"2008","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1907.121830-201306171129-R26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/INF.0b013e318247ef84","article-title":"Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media.","volume":"31","author":"Cohen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid1907.121830-201306171129-R27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/INF.0b013e318187e215","article-title":"Association of serotype of Streptococcus pneumonae with risk of severe and fatal outcome.","volume":"28","author":"R\u00fcckinger","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid1907.121830-201306171129-R28","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1086\/655828","article-title":"Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis.","volume":"51","author":"Weinberger","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1907.121830-201306171129-R29","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1128\/JCM.01937-09","article-title":"Association of serotypes of Streptococcus pneumoniae with age in invasive disease.","volume":"48","author":"Im\u00f6hl","year":"2010","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid1907.121830-201306171129-R30","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1016\/j.vaccine.2006.09.009","article-title":"The role of pneumococcal serotypes 1 and 5 in paediatric invasive disease.","volume":"25","author":"Hausdorff","year":"2007","journal-title":"Vaccine"},{"key":"key-10.3201\/eid1907.121830-201306171129-R31","doi-asserted-by":"publisher","first-page":"7207","DOI":"10.1016\/j.vaccine.2011.06.056","article-title":"The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.","volume":"29","author":"Cooper","year":"2011","journal-title":"Vaccine"},{"key":"key-10.3201\/eid1907.121830-201306171129-R32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1086\/341072","article-title":"Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States.","volume":"186","author":"Beall","year":"2002","journal-title":"J Infect Dis"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/19\/7\/12-1830_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T04:21:07Z","timestamp":1733286067000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/19\/7\/12-1830_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1907.121830","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}